Mrs Wilda Leella Orewiler, PAC in Stuart, IA - Family Medicine

Mrs Wilda Leella Orewiler, PAC is a Family Medicine physician based in Stuart, Iowa. Mrs Wilda Leella Orewiler is licensed to practice in Iowa (license number 000971) and her current practice location is 106 Ne 2nd St, Stuart, Iowa. She can be reached at her office (for appointments etc.) via phone at (515) 523-2283.

NPI number for Mrs Wilda Leella Orewiler is 1396726105 and her current mailing address is Po Box 196, Stuart, Iowa. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1396726105.

Contact Information

	Mrs Wilda Leella Orewiler, PAC
	106 Ne 2nd St, Stuart, IA 50250
	(515) 523-2283
	(515) 523-2786

Physician's Profile

Full Name	Mrs Wilda Leella Orewiler
Gender	Female
Speciality	Family Medicine
Location	106 Ne 2nd St, Stuart, Iowa
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1396726105
Provider Enumeration Date: 11/09/2005
Last Update Date: 09/24/2008

Medical Identifiers

Medical identifiers for Mrs Wilda Leella Orewiler such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1396726105	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Q00000X	Family Medicine	000971 (Iowa)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mrs Wilda Leella Orewiler is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mrs Wilda Leella Orewiler, PAC Po Box 196, Stuart, IA 50250 Ph: (515) 523-2283	Mrs Wilda Leella Orewiler, PAC 106 Ne 2nd St, Stuart, IA 50250 Ph: (515) 523-2283

News Archive

Family instability and child well being

In an age when cohabitation and divorce are common, single parents concerned about the developmental health of their children may want to choose new partners slowly and deliberately, new research from The Johns Hopkins University suggests.

Abbott issues statement in response to FDA's mixed vote for weight loss medication sibutramine

The U.S. Food and Drug Administration today held an Endocrinologic and Metabolic Drugs Advisory Committee to review the results of SCOUT and the weight loss medication sibutramine (sold as Meridia® in the United States).

FDA EMDAC to discuss Arena's lorcaserin NDA resubmission in second quarter

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration (FDA) has notified Arena that an Endocrinologic and Metabolic Drugs Advisory Committee meeting to discuss the lorcaserin New Drug Application (NDA) resubmission will be held in the second quarter of 2012. Confirmation and details of the meeting will be published in the Federal Register.

Prevalence of SARS-CoV-2 antibodies in Germany

Seroprevalence studies have proved their worth in estimating the size and directionality of an outbreak of infectious disease, especially the current pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced coronavirus disease 2019 (COVID-19). A new study posted to the medRxiv* preprint server describes the prevalence of SARS-CoV-2 antibodies in five representative regions of Germany.

Mrs Wilda Leella Orewiler, PAC - Family Medicine in Stuart, IA